A clinical trial to study the effects of two radiotherapy schedules, conventional and hypofractionated, following mastectomy operation in female breast cancer patients with locally advanced disease
- Conditions
- Health Condition 1: null- Adjuvant Radiotherapy in Female Breast Cancer Patients
- Registration Number
- CTRI/2018/04/013174
- Lead Sponsor
- Dr Partha Pratim Medhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Female patients with histologically confirmed invasive breast cancer, who underwent modified radical mastectomy and planned for adjuvant radiotherapy as per Institutional Tumour Board decision
Patients tumours with pathological stage IIA-IIIC
Any patient who had received neoadjuvant chemotherapy
Patients with normal haematological, cardiac and pulmonary functions prior to radiotherapy
Patients must provide study specific informed consent prior to study entry.
Patients with clinical N3 disease with metastatic supraclavicuar lymphadenopathy
Patients with Stage IV metastatic disease
Patients with tangential beam margins separation more than 22 cm
Patients with non-epithelial malignancies
Patients with co-existent or previous history of other malignancy
Patients who received prior radiotherapy to chest wall region
Patients with severe physical or mental co-morbidities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method